Affinimark Technologies is a Connecticut based, privately held, medical diagnostic company, focused on developing streamlined, timely and accurate diagnostic tools for health care providers and patients.
With over 25 years of clinical, scientific and business experience in the field of medicine and developing technologies, the Affinimark Team is dedicated to delivering the highest quality of products to improve the field of medicine.
Harry H. Penner, Jr.
Co-Founder and Chairman
In addition to Affinimark, Harry is Co-Founder and Executive Chairman of New Haven Pharmaceuticals, and has previously co-founded six other biotechnology companies including Rib-X Pharmaceuticals, Marinus Pharmaceuticals, Prevention Pharmaceuticals, RxGen, MAKScientific and RHEI Pharmaceuticals. He served as President, Chief Executive Officer and Vice Chairman of Neurogen Corporation, a publicly-traded biotechnology company from 1993 to 2001, and served as the Executive Vice President of Novo Nordisk A/S in Denmark and the US from 1985 to 1993. Additionally, Harry has served as Chair of the Connecticut Technology Council and Chair of the Connecticut Board of Governors of Higher Education.
Harry holds a B.A. from the University of Virginia, a J.D. from Fordham University, and an L.L.M. in International Law from New York University.
Eleanor L. Tandler
Ellie is a business executive with proven ability to conceive, develop, lead, problem solve and execute in the healthcare space. She has a track record of motivating and developing high-performing teams. With a focus on healthcare, she has over 20 years of experience working in startup leadership roles, venture capital and strategic consulting for companies like UConn Ventures, Radius Ventures and Ernst & Young LLP. Ellie is a former member of the Advisory Committee for the Connecticut Bioscience Innovation Fund and Connecticut Technology Council and currently sits on the Board of Directors of CURE.
Ellie received a Master’s in Business Administration from New York University’s Stern School of Business and earned a Bachelor of Arts Degree in Economics with honors from the University of Massachusetts at Amherst.
Vincent Pieribone, PhD
In addition to Affinimark, Dr. Pieribone Co-founded Marinus Pharmaceuticals, Inc. in 2004 and served as its Chief Scientific Officer and Founding Discovery Officer. He has co-authored over 40 scientific articles in scientific journals including Science, Nature and the Proceedings of the National Academy of Science.
Dr. Pieribone received his B.S. and Ph.D. in Neurobiology from New York University and received post-doctoral training in the Nobel Institute of Neurophysiology at the Karolinska Institute in Stockholm Sweden, and in the Laboratory of Dr. Paul Greengard at The Rockefeller University.
Elias Michaelides, MD
Scientific & Clinical Advisor
Currently Dr. Michaelides serves as an Associate Professor of Surgery in Otolaryngology, Assistant Professor of Pediatrics, Director of the Yale Hearing & Balance Program and the Otolaryngology Program Director.
He received a BA from Cornell University and his MD from SUNY-Stony Brook. He completed a residency in Otolaryngology/Head and Neck Surgery at the Medical College of Virginia. After completing a Fellowship in Otology, Neurotology, and Skull Base Surgery at the Michigan Ear Institute, he stayed on as faculty there for four years.
Advisor Product Development & Manufacturing
Steve received a Master’s in Mechanical Engineering from M.I.T. in 1991 with 3 years in the Medical Engineering/Medical Physics Program (M.E.M.P.) within the Harvard/MIT Division of Healthy Sciences and Technology. He also received his Bachelor’s in Mechanical Engineering from M.I.T. in 1988.
Advisor Regulatory Affairs
Fred earned his Ph.D. in chemistry from SUNY at Buffalo and did post-doctoral training in physiology, biomedicine and laboratory medicine at the Albert Einstein College of Medicine in New York. He is a Fellow of the National Academy of Clinical Biochemists.